Загрузка...
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
A growing body of pathological, biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in production, processing, and/or clearance of brain amyloid-β peptide (Aβ) concentrations, plays a key role in the pathogenesis of Alzheimer’s disease (AD). Beta-secre...
Сохранить в:
| Опубликовано в: : | J Alzheimers Dis |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
IOS Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927864/ https://ncbi.nlm.nih.gov/pubmed/26890753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-150834 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|